glp 1 vs gip Science Behind and Glucagon Receptor Agonists for Obesity Research | News & Announcements Targeting GLP-1, GIP & GCG

Discover how microdosing GLP-1s can have low side effects, low costs, and support weight loss

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

The Complete Daily Wellness Stack is for adults using GLP-1 medications who want support for protein intake, digestive comfort, regularity, and joint mobility

[Gut-Driven Sugar Spike Support] Helps maintain healthy sugar levels already within normal range

Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies

Reduced appetite and cravings